Skip to main content
SpringerLink
Log in

Cardiovascular Risk of Migraine in Men and Women

  • Chapter
  • First Online:
Gender and Migraine

Part of the book series: Headache ((HEAD))

Abstract

The association of migraine, particularly migraine with aura—characterized by focal neurological symptoms—and different forms of cardiovascular disease and cardiovascular mortality has been a topic of much debate. However, with recent advances made in this field, migraine with aura has now been acknowledged as an established risk factor for (subclinical) ischemic lesions in the brain and white matter lesions. Moreover, a broader range of ischemic vascular disorders, including myocardial ischemia, has been studied. Although migraine mainly affects young women and the majority of data available on an association with cardiovascular disease is based on females, an association between migraine and cardiovascular disease has also been observed in men. The assumption that the presence or absence of cardiovascular disease influences the additional cardiovascular risk associated with migraine therefore may have consequences for the choices of pharmacological antimigraine treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sacco SCA. Migraine: an emerging cardiovascular risk factor. Cardiol Clin Pract. 2010;2(1):53–65.

    Google Scholar 

  2. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology. 2009;72(21):1864–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Tepper D. Migraine and cardiovascular disease. Headache. 2014;54(7):1267–8.

    Article  PubMed  Google Scholar 

  4. Hu X, Zhou Y, Zhao H, Peng C. Migraine and the risk of stroke: an updated meta-analysis of prospective cohort studies. Neurol Sci. 2017;38(1):33–40.

    Article  PubMed  Google Scholar 

  5. Linstra KM, Ibrahimi K, Terwindt GM, Wermer MJ, MaassenVanDenBrink A. Migraine and cardiovascular disease in women. Maturitas. 2017;97:28–31.

    Article  PubMed  Google Scholar 

  6. Sacco S, Bushell C. Cardio-cerebrovascular comorbidity. In: Giamberardino MA, Martelletti P, editors. Comorbidities of headache disorders. New York, NY: Springer; 2017. p. 1–21.

    Google Scholar 

  7. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sacco S, Ornello R, Ripa P, Tiseo C, Degan D, Pistoia F, et al. Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies. Eur J Neurol. 2015;22(6):1001–11.

    Article  CAS  PubMed  Google Scholar 

  9. Kurth T, Winter AC, Eliassen AH, Dushkes R, Mukamal KJ, Rimm EB, et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ. 2016;353:i2610.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wang YC, Lin CW, Ho YT, Huang YP, Pan SL. Increased risk of ischemic heart disease in young patients with migraine: a population-based, propensity score-matched, longitudinal follow-up study. Int J Cardiol. 2014;172(1):213–6.

    Article  PubMed  Google Scholar 

  11. Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, et al. Migraine and cardiovascular disease: a population-based study. Neurology. 2010;74(8):628–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Gudmundsson LS, Scher AI, Aspelund T, Eliasson JH, Johannsson M, Thorgeirsson G, et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ. 2010;341:c3966.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med. 2007;167(8):795–801.

    Article  PubMed  Google Scholar 

  14. Ahmed B, Bairey Merz CN, McClure C, Johnson BD, Reis SE, Bittner V, et al. Migraines, angiographic coronary artery disease and cardiovascular outcomes in women. Am J Med. 2006;119(8):670–5.

    Article  PubMed  Google Scholar 

  15. Velentgas P, Cole JA, Mo J, Sikes CR, Walker AM. Severe vascular events in migraine patients. Headache. 2004;44(7):642–51.

    Article  PubMed  Google Scholar 

  16. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology. 2004;62(4):563–8.

    Article  CAS  PubMed  Google Scholar 

  17. Sternfeld B, Stang P, Sidney S. Relationship of migraine headaches to experience of chest pain and subsequent risk for myocardial infarction. Neurology. 1995;45(12):2135–42.

    Article  CAS  PubMed  Google Scholar 

  18. Schwedt TJ. The migraine association with cardiac anomalies, cardiovascular disease, and stroke. Neurol Clin. 2009;27(2):513–23.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Alqaqa A. The Association of cardiovascular disease and migraine: review. J Clini Exp Cardiol. 2016;7(8):465.

    Article  CAS  Google Scholar 

  20. Kruit MC, Van Buchem MA, Hofman PAM, Bakkers JTN, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291(4):427–34.

    Article  CAS  PubMed  Google Scholar 

  21. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017;18(1):108.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168–75.

    Article  CAS  PubMed  Google Scholar 

  23. Sacco S, Ripa P, Grassi D, Pistoia F, Ornello R, Carolei A, et al. Peripheral vascular dysfunction in migraine: a review. J Headache Pain. 2013;14:80.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Settakis G, Lengyel A, Molnár C, Bereczki D, Csiba L, Fülesdi B. Transcranial doppler study of the cerebral hemodynamic changes during breath-holding and hyperventilation tests. J Neuroimaging. 2002;12:252–8.

    Article  PubMed  Google Scholar 

  25. Ibrahimi K, De Graaf Y, Draijer R, Danser AHJ, Maassen VanDenBrink A, Van den Meiracker AH. Reproducibility and agreement of Different non-invasive methods of endothelial function assessment. Microvasc Res. 2018;117:50–6.

    Article  CAS  PubMed  Google Scholar 

  26. Butt JH, Franzmann U, Kruuse C. Endothelial function in migraine with aura - a systematic review. Headache. 2015;55(1):35–54.

    Article  PubMed  Google Scholar 

  27. Kernick D. Statins for all: should patients who have migraine with aura be on a statin? Br J Gen Pract. 2015;65(640):571–2.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Hanington E. Migraine: the platelet hypothesis after 10 years. Biomed Pharmacother. 1989;43(10):719–26.

    Article  CAS  PubMed  Google Scholar 

  29. Danese E, Montagnana M, Lippi G. Platelets and migraine. Thromb Res. 2014;134(1):17–22.

    Article  CAS  PubMed  Google Scholar 

  30. Govitrapong P, Limthavon C, Srikiatkhachorn A. 5-HT2 serotonin receptor on blood platelet of migraine patients. Headache. 1992;32(10):480–4.

    Article  CAS  PubMed  Google Scholar 

  31. Kozubski W, Walkowiak B, Cierniewski CS, Prusinski A. Platelet fibrinogen receptors in migraine patients. Headache. 1987;27(8):431–4.

    Article  CAS  PubMed  Google Scholar 

  32. Pawlowska Z, Kozubski W, Walkowiak B, Cierniewski CS. Increased platelet glycoprotein IIb reflects an abnormality of the platelet membrane in migraine. Headache. 1988;28(1):60.

    Article  CAS  PubMed  Google Scholar 

  33. Gupta VK. Patent foramen ovale closure and migraine: science and sensibility. Expert Rev Neurother. 2010;10(9):1409–22.

    Article  PubMed  Google Scholar 

  34. Silva IRFG. Migraine patients should be cautiously followed for risk factors leading to cardiovascular disease. Arq Neuropsiquiatr. 2013;71(2):119–24.

    Article  PubMed  Google Scholar 

  35. Dowson AJ, Wilmshurst P, Muir KW, et al. A prospective, multicentre, double-blind, placebo-controlled study to evaluate the efficacy of patent foramen ovale closure for the resolution of refractory migraine headache (the MIST Study): prevalence and size of shunts. Headache Care. 2005;2(4):223–7.

    Article  Google Scholar 

  36. Colson NJ, Fernandez F, Lea RA, Griffiths LR. The search for migraine genes: an overview of current knowledge. Cell Mol Life Sci. 2007;64(3):331–44.

    Article  CAS  PubMed  Google Scholar 

  37. Gormley P, Anttila V, Winsvold BS, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48(8):856–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Winsvold BS, Bettella F, Witoelar A, Anttila V, Gormley P, Kurth T, et al. Shared genetic risk between migraine and coronary artery disease: a genome-wide analysis of common variants. PLoS One. 2017;12(9):e0185663.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Weitzel KW, Strickland JM, Smith KM, Goode JV. Gender-specific issues in the treatment of migraine. J Gend Specif Med. 2001;4(1):64–74.

    CAS  PubMed  Google Scholar 

  40. Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13(3):177–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Cook NR, Benseñor IM, Lotufo PA, Lee I, Skerrett PJ, Chown MJ, Ajani UA, Manson JE, Buring JE. Migraine and coronary heart disease in women and men. Headache. 2002;42:715–27.

    Article  PubMed  Google Scholar 

  42. Cook NR, Bensenor IM, Lotufo PA, Lee IM, Skerrett PJ, Chown MJ, et al. Migraine and coronary heart disease in women and men. Headache. 2002;42(8):715–27.

    Article  PubMed  Google Scholar 

  43. Chai NC, Peterlin BL, Calhoun AH. Migraine and estrogen. Curr Opin Neurol. 2014;27(3):315–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Gupta S, Mehrotra S, Villalon CM, Perusquia M, Saxena PR, MaassenVanDenBrink A. Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol Ther. 2007;113(2):321–40.

    Article  CAS  PubMed  Google Scholar 

  45. Rosano GM, Leonardo F, Sarrel PM, Beale CM, De Luca F, Collins P. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet. 1996;347(9004):786–8.

    Article  CAS  PubMed  Google Scholar 

  46. Lloyd GW, Patel NR, McGing E, Cooper AF, Brennand-Roper D, Jackson G. Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? Heart. 2000;84(2):189–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Choo WK. Menstruation angina: a case report. J Med Case Reports. 2009;3:6618.

    Article  PubMed Central  Google Scholar 

  48. Tietjen GE, Khubchandani J. Vascular biomarkers in migraine. Cephalalgia. 2015;35(2):95–117.

    Article  PubMed  Google Scholar 

  49. Tietjen GE, Khubchandani J, Herial N, Palm-Meinders IH, Koppen H, Terwindt GM, et al. Migraine and vascular disease biomarkers: a population-based case-control study. Cephalalgia. 2018;38:511.

    Article  PubMed  Google Scholar 

  50. Rose KM, Wong TY, Carson AP, Couper DJ, Klein R, Sharrett AR. Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology. 2007;68(20):1694–700.

    Article  CAS  PubMed  Google Scholar 

  51. Stam AH, Weller CM, Janssens ACJW, Aulchenko YS, Oostra BA, Frants RR, Van den Maagdenberg AMJM, Ferrari MD, Van Duijn CM, Terwindt GM. Migraine is not associated with enhanced atherosclerosis. Cephalalgia. 2013;33(4):228–35.

    Article  PubMed  Google Scholar 

  52. Kurth T, Diener HC. Migraine and stroke: perspectives for stroke physicians. Stroke. 2012;43(12):3421–6.

    Article  PubMed  Google Scholar 

  53. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 1999;318(7175):13–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Gilad R, Boaz M, Dabby R, Finkelstein V, Rapoport A, Lampl Y. Migraine and vascular risk factors in the elderly. Geriatr Gerontol Int. 2014;14(1):220–5.

    Article  PubMed  Google Scholar 

  55. John S, Schneider MP, Delles C, Jacobi J, Schmieder RE. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J. 2005;149(3):473.

    Article  PubMed  CAS  Google Scholar 

  56. Kurth T, Diener HC, Buring JE. Migraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women’s Health Study. Cephalalgia. 2011;31(10):1106–15.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Roberto G, Raschi E, Piccinni C, Conti V, Vignatelli L, D’Alessandro R, et al. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies. Cephalalgia. 2015;35(2):118–31.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisionof Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands

    L. Al-Hassany, K. A. Linstra & Antoinette Maassen van den Brink

  2. Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands

    K. A. Linstra & G. M. Terwindt

Authors
  1. L. Al-Hassany
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. A. Linstra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. M. Terwindt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antoinette Maassen van den Brink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antoinette Maassen van den Brink .

Editor information

Editors and Affiliations

  1. Division of Pharmacology and Vascular Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands

    Antoinette Maassen van den Brink

  2. Barts Health NHS Trust, London, UK

    E. Anne MacGregor

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Al-Hassany, L., Linstra, K.A., Terwindt, G.M., van den Brink, A.M. (2019). Cardiovascular Risk of Migraine in Men and Women. In: Maassen van den Brink, A., MacGregor, E. (eds) Gender and Migraine. Headache. Springer, Cham. https://doi.org/10.1007/978-3-030-02988-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-02988-3_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-02987-6

  • Online ISBN: 978-3-030-02988-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation